Summary & Overview
HCPCS Level II S4990: Nicotine Patches, Legend
HCPCS Level II code S4990 denotes nicotine patches (legend), a form of transdermal nicotine replacement therapy used to support tobacco cessation. This code is nationally relevant as nicotine replacement therapies are commonly prescribed and reimbursed across payers to address smoking-related morbidity and public health goals.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for S4990, typical sites of service (pharmacy or outpatient clinic), and the common billing environment for legend transdermal products. The publication provides benchmarks and payer coverage context, highlights coding and billing considerations for transdermal nicotine therapy, and summarizes potential policy or coverage guidance that affects access and reimbursement for nicotine patches.
This national-level summary is intended to inform billing teams, pharmacy managers, and policy analysts about the role of S4990 in clinical tobacco cessation workflows and payer coverage patterns. Data not available in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code S4990 describes nicotine patches, legend. This code represents a transdermal nicotine replacement therapy product intended to deliver controlled doses of nicotine through the skin to assist with tobacco cessation.
Service Type: Nicotine replacement therapy (transdermal)
Typical Site of Service: Retail pharmacy or outpatient clinic setting where prescription legend patches are dispensed or administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A middle-aged adult who uses combustible tobacco presents to a primary care clinic seeking assistance to quit smoking. The clinician performs a brief tobacco use assessment, documents tobacco dependence and readiness to quit, and provides counseling. As part of a smoking cessation plan, the clinician prescribes nicotine transdermal patches (S4990) as a legend medication. The typical workflow includes evaluation of medical history (e.g., cardiovascular disease, pregnancy), assessment of nicotine dependence, selection of patch strength and duration, counseling on proper application and side effects, and scheduling follow-up to monitor cessation progress and adverse effects. The typical site of service is an outpatient clinic, primary care office, or community health center where prescription and patient education are delivered and documented.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when additional work beyond typical prescribing and counseling is documented (rare for patch alone). |
23 | Unusual anesthesia |